WallStreetZenWallStreetZen

NYSEMKT: AEON
Aeon Biopharma Inc Stock Ownership - Who owns Aeon Biopharma?

Insider buying vs selling

Have Aeon Biopharma Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Strathspey Crown Holdings Group LLC10% Owner2023-08-117,380,394$10.00
$73.80MSell

1 of 1

AEON insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AEON insiders and whales buy or sell their stock.

AEON Shareholders

What type of owners hold Aeon Biopharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Priveterra Sponsor LLC35.50%13,889,163$21.25MInsider
Daewoong Co Ltd16.81%6,577,604$10.06MInsider
Polar Asset Management Partners Inc9.39%3,675,000$5.62MInstitution
Atalaya Capital Management LP9.39%3,675,000$5.62MInstitution
Strathspey Crown Holdings Group LLC5.19%2,031,773$3.11MInsider
Vanguard Group Inc1.94%758,992$1.16MInstitution
Barclays PLC1.80%702,645$1.08MInsider
Ikarian Capital LLC0.66%257,977$394.70kInstitution
Blackrock Inc0.65%255,423$390.80kInstitution
Geode Capital Management LLC0.46%179,595$274.78kInstitution

1 of 3

AEON vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AEON24.21%59.31%Net Selling
ANEB24.91%75.09%
OCEA13.26%75.32%
GNTA2.37%0.00%
THTX31.05%0.00%

Aeon Biopharma Stock Ownership FAQ

Who owns Aeon Biopharma?

Aeon Biopharma (NYSEMKT: AEON) is owned by 24.21% institutional shareholders, 59.31% Aeon Biopharma insiders, and 16.48% retail investors. Priveterra Sponsor LLC is the largest individual Aeon Biopharma shareholder, owning 13.89M shares representing 35.50% of the company. Priveterra Sponsor LLC's Aeon Biopharma shares are currently valued at $21.25M.

If you're new to stock investing, here's how to buy Aeon Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.